Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 249,958
  • Shares Outstanding, K 43,471
  • Annual Sales, $ 3,500 K
  • Annual Income, $ -54,190 K
  • EBIT $ -61 M
  • EBITDA $ -58 M
  • 60-Month Beta 1.52
  • Price/Sales 73.16
  • Price/Cash Flow N/A
  • Price/Book 5.57

Options Overview Details

View History
  • Implied Volatility 104.93% ( +5.19%)
  • Historical Volatility 37.36%
  • IV Percentile 47%
  • IV Rank 29.96%
  • IV High 309.58% on 07/19/24
  • IV Low 17.40% on 09/06/24
  • Put/Call Vol Ratio 0.45
  • Today's Volume 96
  • Volume Avg (30-Day) 137
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 4,972
  • Open Int (30-Day) 4,508

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.35
  • Number of Estimates 4
  • High Estimate -0.32
  • Low Estimate -0.39
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +45.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.62 +3.02%
on 11/21/24
6.78 -14.60%
on 11/12/24
-0.76 (-11.60%)
since 10/21/24
3-Month
5.08 +13.98%
on 08/22/24
6.78 -14.60%
on 11/12/24
+0.55 (+10.50%)
since 08/21/24
52-Week
3.05 +89.84%
on 04/25/24
9.01 -35.74%
on 03/06/24
+1.62 (+38.85%)
since 11/21/23

Most Recent Stories

More News
Abeona Therapeutics' BLA Resubmission for Pz-Cel in RDEB Accepted by FDA, PDUFA Date Set for April 29, 2025

FDA accepted Abeona's BLA resubmission for pz-cel, setting a target action date of April 29, 2025.Quiver AI SummaryAbeona Therapeutics Inc. announced that the FDA has accepted its resubmission of the Biologics...

ABEO : 5.79 (+0.70%)
Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 5.79 (+0.70%)
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates

ABEO : 5.79 (+0.70%)
Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa

ABEO : 5.79 (+0.70%)
Abeona Therapeutics® Announces Participation in November Investor Conferences

ABEO : 5.79 (+0.70%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 5.79 (+0.70%)
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

ABEO : 5.79 (+0.70%)
Abeona Therapeutics: Q2 Earnings Snapshot

Abeona Therapeutics: Q2 Earnings Snapshot

ABEO : 5.79 (+0.70%)
Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 5.79 (+0.70%)
Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 5.79 (+0.70%)

Business Summary

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

See More

Key Turning Points

3rd Resistance Point 6.35
2nd Resistance Point 6.17
1st Resistance Point 5.98
Last Price 5.79
1st Support Level 5.61
2nd Support Level 5.43
3rd Support Level 5.24

See More

52-Week High 9.01
Fibonacci 61.8% 6.73
Fibonacci 50% 6.03
Last Price 5.79
Fibonacci 38.2% 5.33
52-Week Low 3.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar